FDA Inspection 1102682 — Michael J. Downing, M.D.
The FDA completed an inspection of Michael J. Downing, M.D. on Aug 22, 2019 in Dallas, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 22, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Dallas, TX (United States)
Additional details
Clinical Investigator (CI)